Select Page
TGA Approves Global Sarcoma Therapy

TGA Approves Global Sarcoma Therapy

The Therapeutic Goods Administration (TGA) has approved the use of Global Sarcoma Therapy called YONDELISÒ, marketed by Specialised Therapeutics, for Australian patients afflicted with “unresectable or metastatic liposarcoma or leiomyosarcoma who received a...